Target intelligence / Profile preview

Gastrulation brain homeobox 2 (GBX2)

Target
GBX2
Molecular classification
Transcription factor, Homeobox protein
01

Overview

**Gastrulation brain homeobox 2 (GBX2)** is a transcription factor encoded by the GBX2 gene, belonging to the homeobox protein family[1][4][6]. It is a sequence-specific DNA-binding protein crucial for the development and regionalization of the central nervous system, particularly of the midbrain and hindbrain during embryogenesis[1][2][4]. GBX2 regulates the segmentation of the hindbrain into rhombomeres 1-3 and influences the expression of other developmental genes such as FGF8 and Otx2[1][4]. Its activity is essential for neural crest cell migration, nervous system patterning, and aspects of cardiovascular development[4]. Dysregulation or mutation of GBX2 is associated with congenital anomalies (including Opitz-Gbbb syndrome and craniofacial/cardiovascular defects) and has been linked to certain cancers[1][2]. There are currently no drugs known to directly target GBX2, nor is it considered a therapeutic target; its essential role in fundamental developmental processes makes it primarily of interest for developmental biology and genetics, not for drug targeting[1][6].

Other names
Homeobox protein GBX-2GBX2Gastrulation and brain-specific homeobox protein 2homeobox protein GBX-2gastrulation and brain-specific homeobox protein 2
02

Mechanism of action

Not applicable (no known or reported drugs directly targeting GBX2 as a therapeutic mechanism)

03

Biological functions

Regulation of transcription by RNA polymerase IIRegulation of nervous system developmentNeural crest cell migration and patterningBrain regionalization (especially midbrain, hindbrain, and telencephalon)Cardiovascular developmentCell pluripotency and differentiation in embryo
04

Disease associations

Cancer (e.g., colon small cell carcinoma)Congenital syndromes (e.g., Opitz-Gbbb syndrome, affecting midline development)Cardiovascular defects (secondary to neural crest migration defects)Craniofacial malformation
05

Safety considerations

Not applicable (not a therapeutic target; critical for embryonic development, so perturbation could confer teratogenic effects)

Beyond the preview

Go deeper on Gastrulation brain homeobox 2 (GBX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrulation brain homeobox 2 (GBX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call